title: Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines.
abstract: Attenuated viral vaccines can be generated by targeting essential pathogenicity factors. We report here the rational design of an attenuated recombinant coronavirus vaccine based on a deletion in the coding sequence of the non-structural protein 1 (nsp1). In cell culture, nsp1 of mouse hepatitis virus (MHV), like its SARS-coronavirus homolog, strongly reduced cellular gene expression. The effect of nsp1 on MHV replication in vitro and in vivo was analyzed using a recombinant MHV encoding a deletion in the nsp1-coding sequence. The recombinant MHV nsp1 mutant grew normally in tissue culture, but was severely attenuated in vivo. Replication and spread of the nsp1 mutant virus was restored almost to wild-type levels in type I interferon (IFN) receptor-deficient mice, indicating that nsp1 interferes efficiently with the type I IFN system. Importantly, replication of nsp1 mutant virus in professional antigen-presenting cells such as conventional dendritic cells and macrophages, and induction of type I IFN in plasmacytoid dendritic cells, was not impaired. Furthermore, even low doses of nsp1 mutant MHV elicited potent cytotoxic T cell responses and protected mice against homologous and heterologous virus challenge. Taken together, the presented attenuation strategy provides a paradigm for the development of highly efficient coronavirus vaccines.
authors: Research Department, Kantonal Hospital St. Gallen, St. Gallen, Switzerland.
authors: Roland
authors: R
authors: Züst
authors: Luisa
authors: L
authors: Cervantes-Barragán
authors: Thomas
authors: T
authors: Kuri
authors: Gjon
authors: G
authors: Blakqori
authors: Friedemann
authors: F
authors: Weber
authors: Burkhard
authors: B
authors: Ludewig
authors: Volker
authors: V
authors: Thiel
mesh_terms: D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D004279:DNA, Viral; D004195:Disease Models, Animal; D015195:Drug Design; D017353:Gene Deletion; D020868:Gene Silencing; D006524:Hepatitis, Viral, Animal / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007370:Interferon Type I / Q000172:deficiency / Q000235:genetics; D008099:Liver / Q000378:metabolism / Q000473:pathology / Q000821:virology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D006517:Murine hepatitis virus / Q000276:immunology* / Q000472:pathogenicity*; D011994:Recombinant Proteins / Q000276:immunology; D014613:Vaccines, Attenuated / Q000276:immunology; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D014765:Viral Vaccines / Q000276:immunology*; D037521:Virulence Factors / Q000276:immunology*; D014779:Virus Replication
chemical_list: D004279:DNA, Viral; D007370:Interferon Type I; C505227:NSP1 protein, murine hepatitis virus; D011994:Recombinant Proteins; D014613:Vaccines, Attenuated; D017361:Viral Nonstructural Proteins; D014765:Viral Vaccines; D037521:Virulence Factors
references: J Virol. 2003 Sep;77(18):9790-8
references: 12941887
references: J Virol. 2007 Apr;81(7):3151-61
references: 17202208
references: Trends Immunol. 2005 Jan;26(1):13-8
references: 15629404
references: Blood. 2005 Oct 1;106(7):2366-74
references: 15860669
references: J Virol. 2007 Mar;81(6):2554-63
references: 17182678
references: Immunology. 2000 Feb;99(2):163-9
references: 10692032
references: J Virol. 2005 Oct;79(20):12721-31
references: 16188975
references: J Virol. 2006 Nov;80(22):11009-18
references: 16943300
references: Virology. 2002 Apr 25;296(1):177-89
references: 12036329
references: J Mol Biol. 2003 Aug 29;331(5):991-1004
references: 12927536
references: Nat Rev Immunol. 2005 Dec;5(12):917-27
references: 16322745
references: J Virol. 2005 Nov;79(21):13399-411
references: 16227261
references: J Virol. 2005 Jan;79(2):1036-44
references: 15613332
references: J Gen Virol. 2004 Jun;85(Pt 6):1717-25
references: 15166457
references: Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12885-90
references: 16912115
references: Virology. 2003 Mar 30;308(1):13-22
references: 12706086
references: FEMS Microbiol Rev. 2006 Sep;30(5):760-73
references: 16911043
references: Science. 2006 Nov 10;314(5801):997-1001
references: 17038589
references: J Virol. 2004 Apr;78(8):3863-71
references: 15047802
references: J Biol Chem. 1998 Apr 10;273(15):8699-704
references: 9535846
references: Science. 2005 Oct 28;310(5748):676-9
references: 16195424
references: Nat Med. 2005 Apr;11(4 Suppl):S54-62
references: 15812491
references: Science. 2003 May 30;300(5624):1399-404
references: 12730501
references: J Virol. 2002 Feb;76(3):1422-34
references: 11773416
references: Virology. 2005 Sep 30;340(2):209-23
references: 16051301
references: J Virol. 2005 Mar;79(5):3097-106
references: 15709029
references: Curr Top Microbiol Immunol. 2005;287:161-97
references: 15609512
references: J Virol. 2006 Mar;80(5):2506-14
references: 16474157
references: Blood. 2007 Feb 1;109(3):1131-7
references: 16985170
references: J Am Geriatr Soc. 1997 Jun;45(6):706-11
references: 9180664
references: J Virol. 2007 Jan;81(2):548-57
references: 17108024
references: Nat Med. 2005 Apr;11(4 Suppl):S5-11
references: 15812490
references: J Virol. 2002 Nov;76(22):11518-29
references: 12388713
references: Science. 1994 Jun 24;264(5167):1918-21
references: 8009221
references: Adv Exp Med Biol. 2006;581:203-6
references: 17037531
references: Lancet. 2006 Feb 4;367(9508):425-35
references: 16458769
references: J Gen Virol. 2001 Jun;82(Pt 6):1273-81
references: 11369870
references: J Virol. 2005 Mar;79(6):3391-400
references: 15731233
references: Nature. 2003 May 15;423(6937):240
references: 12748632
references: J Virol Methods. 1991 Jun;33(1-2):191-8
references: 1939506
references: Virology. 2006 Jan 5;344(1):119-30
references: 16364743
references: Science. 2003 May 30;300(5624):1394-9
references: 12730500
references: PLoS Pathog. 2007 Jan;3(1):e5
references: 17222058
references: Curr Infect Dis Rep. 2004 Apr;6(2):96-104
references: 15023271
references: EMBO J. 1998 Feb 16;17(4):1087-95
references: 9463386
references: J Virol. 2005 Jun;79(12):7819-26
references: 15919935
references: J Virol. 2007 Jan;81(2):813-21
references: 17079315
references: Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64
references: 16339739
references: Virology. 2006 Jan 5;344(1):9-16
references: 16364730
references: Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8275-80
references: 15919828
references: Cell. 2006 Feb 24;124(4):849-63
references: 16497593
references: J Virol. 2004 May;78(10):5486-90
references: 15113927
references: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4309-14
references: 10725408
references: Curr Top Microbiol Immunol. 2005;287:57-94
references: 15609509
references: J Virol. 2007 Feb;81(3):1162-73
references: 17108019